HBMN Stock Overview
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 2/6 |
HBM Healthcare Investments AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF188.00 |
| 52 Week High | CHF214.00 |
| 52 Week Low | CHF135.20 |
| Beta | 0.80 |
| 1 Month Change | -1.05% |
| 3 Month Change | 4.79% |
| 1 Year Change | -7.39% |
| 3 Year Change | -41.98% |
| 5 Year Change | 11.37% |
| Change since IPO | 218.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| HBMN | CH Capital Markets | CH Market | |
|---|---|---|---|
| 7D | 1.5% | -2.4% | 0.03% |
| 1Y | -7.4% | 27.4% | -3.3% |
Return vs Industry: HBMN underperformed the Swiss Capital Markets industry which returned 27.9% over the past year.
Return vs Market: HBMN underperformed the Swiss Market which returned -2.5% over the past year.
Price Volatility
| HBMN volatility | |
|---|---|
| HBMN Average Weekly Movement | 4.1% |
| Capital Markets Industry Average Movement | 3.3% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.5% |
| 10% least volatile stocks in CH Market | 2.0% |
Stable Share Price: HBMN has not had significant price volatility in the past 3 months.
Volatility Over Time: HBMN's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Andreas Wicki | www.hbmhealthcare.com |
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds.
HBM Healthcare Investments AG Fundamentals Summary
| HBMN fundamental statistics | |
|---|---|
| Market cap | CHF1.30b |
| Earnings (TTM) | -CHF149.14m |
| Revenue (TTM) | n/a |
-9.0x
P/S Ratio-8.7x
P/E RatioIs HBMN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HBMN income statement (TTM) | |
|---|---|
| Revenue | -CHF145.09m |
| Cost of Revenue | CHF0 |
| Gross Profit | -CHF145.09m |
| Other Expenses | CHF4.05m |
| Earnings | -CHF149.14m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | -21.58 |
| Gross Margin | 100.00% |
| Net Profit Margin | 102.79% |
| Debt/Equity Ratio | 13.8% |
How did HBMN perform over the long term?
See historical performance and comparison